NCT03148210

Undiagnosed COPD and Asthma Population Study (UCAP)

A Randomized, Controlled, Clinical Trial to Address the Burden of Undiagnosed Airflow Obstruction in Canadian Adults

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 508 (actual)
• Sponsor: Ottawa Hospital Research Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Previous population health studies suggest that up to 10% of Canadian adults have undiagnosed asthma or COPD- these people are currently undiagnosed and untreated, even though they may have significant respiratory symptoms. Our study will use targeted casefinding to find people with undiagnosed asthma and COPD in Canadian communities. The investigators will assess their symptoms and their health care use and number of sick days to determine the burden of undiagnosed respiratory disease in these people. The investigators will then determine whether early treatment of previously undiagnosed airflow obstruction will improve patients' health outcomes.

Conditions

• Asthma
• COPD

Interventions

Type	Name	Description
DRUG	Treatment strategy using evidence-based guidelines for asthma or COPD	The respirologist will determine the clinical extent of the patient's symptoms, activity limitation, and degree of airflow obstruction and will commence the subject on asthma or COPD medications if indicated
BEHAVIORAL	Smoking Cessation	Smoking cessation counselling by a qualified educator if currently smoking
BEHAVIORAL	Participant Education	Standardized education for asthma or COPD disease

Timeline

• Start date: 2017-06-05
• Primary completion: 2024-01-09
• Completion: 2024-01-09
• First posted: 2017-05-10
• Last updated: 2024-03-07

Locations

15 sites across 1 country: Canada